RIVASTIGMINE TARTRATE 4.5 mg/1 (Rivastigmine Tartrate CAPSULE) 4.5 mg/1

Rivastigmine Tartrate 4.5 mg capsules are used to manage symptoms of Alzheimer's and Parkinson's disease. This oral medication supports cognitive function and may improve daily living activities.

Strength

4.5 mg/1

Pack Size

60 CAPSULE in 1 BOTTLE (33342-091-09)

Manufacturer / TM Owner

Macleods Pharmaceuticals Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Rivastigmine Tartrate is primarily used to treat mild to moderate dementia related to Alzheimer's and Parkinson's diseases. It works by increasing certain chemicals in the brain that are important for cognitive functions. People often ask, 'What is Rivastigmine Tartrate used for?' It is commonly prescribed to help manage symptoms like memory loss, confusion, and difficulty with thinking and reasoning.

Side Effects

Common effects of Rivastigmine Tartrate may include nausea, vomiting, dizziness, and loss of appetite. Some users also report headaches, fatigue, and stomach pain. These effects can vary in intensity and duration depending on the individual.

Precautions & Warnings

Rivastigmine Tartrate should be handled with care. It is important to follow the prescribed dosage and administration instructions. Avoid alcohol while taking this medication, as it may increase the risk of side effects. Store the capsules in a cool, dry place away from direct sunlight.

Avoid Interactions

Rivastigmine Tartrate may interact with other medications, including those that affect the central nervous system. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain over-the-counter drugs may also interact with Rivastigmine Tartrate.

Frequently Asked Questions

Rivastigmine Tartrate is used to manage symptoms of mild to moderate dementia in Alzheimer's and Parkinson's diseases.

Rivastigmine Tartrate capsules are taken orally, typically with food to reduce stomach upset.

Common side effects include nausea, vomiting, dizziness, and loss of appetite.

It is important to consult a healthcare provider before taking Rivastigmine Tartrate with other medications to avoid potential interactions.

Rivastigmine Tartrate should be stored in a cool, dry place away from direct sunlight.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.